BP Directors, LP's Net Worth
$8.57 Million
Who is BP Directors, LP?
BP Directors, LP has an estimated net worth of $8.57 Million. This is based on reported shares across multiple companies, which include Lantern Pharma Inc., COGNITION THERAPEUTICS INC, and IN8BIO, INC..
SEC CIK
BP Directors, LP's CIK is 0001813311
Past Insider Trading and Trends
2020 was BP Directors, LP's most active year for acquiring shares with 6 total transactions. BP Directors, LP's most active month to acquire stocks was the month of May. 2022 was BP Directors, LP's most active year for disposing of shares, totalling 7 transactions. BP Directors, LP's most active month to dispose stocks was the month of October. 2023 saw BP Directors, LP paying a total of $525,099.75 for 2,222,818 shares, this is the most they've acquired in one year. In 2022 BP Directors, LP cashed out on 356,445 shares for a total of $1,573,514.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COGNITION THERAPEUTICS INC (CGTX) Snapshot price: $2.31
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +141.67% | 8.5K |
—
|
—
| 14.5K |
Jun 7
| |||
Form 4
|
∞
| 500.1K |
$1.05 | $525,099.75 | 500.1K |
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Lantern Pharma Inc. (LTRN) Snapshot price: $4.255
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.63% | -30.00K |
$6.30 | -$189,100.00 | 618.21K |
May 23 - May 24
| |||
Form 4
| -18.18% | -144.00K |
$4.70 | -$676,294.06 | 648.21K |
Feb 27 - Feb 29
| |||
Form 4
| +2.61% | 20.13K |
$3.67 | $1.93 | 792.21K |
Jan 17
| |||
Form 4
| -19.78% | -145.35K |
$3.44 | -$499,997.12 | 589.5K |
Nov 29
| |||
Form 4
| -18.85% | -350.00K |
$4.40 | -$1,540,000.00 | 1.51M |
Nov 8
| |||
Form 4
| +54.07% | 26.09K |
$3.12 | $0.14 | 74.35K |
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 4
| +478.38% | 1.46M |
—
|
—
| 1.76M |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IN8BIO, INC. (INAB) Snapshot price: $1.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACTUATE THERAPEUTICS, INC. (ACTU) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -1.74% | -25.00K |
$8.00 | -$199,992.00 | 1.41M |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 9.89M |
$7.68 | $775,009.00 | 9.89M |
Aug 12 - Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |